Powering Biotech Growth Through Capital and Pharma Partnerships
Bringing together biotech founders and executives, active investors, and pharma leaders to drive funding, partnering, and growth.
Part of Biotech Week Boston
What is LSX Congress USA?
LSX Congress USA (LSX USA) is where biotech companies at different stages of growth come to meet the investors and pharma partners who can help shape what comes next. From emerging biotechs seeking capital and visibility to later-stage companies pursuing strategic partnerships and commercial momentum, the event is built around the conversations that matter most.
Capital to support the next stage of growth
From emerging biotechs preparing for seed to Series A/B conversations to later-stage companies looking to strengthen their funding strategy, LSX USA is designed to connect companies with active investors and the insight needed to move forward with confidence.
Pharma partnerships with strategic value
For biotechs looking beyond capital, LSX USA creates opportunities to connect with pharma leaders around partnering, licensing and long-term strategic growth. It is built to support the conversations that help companies move from innovation to execution.
Focused visibility, partnering and momentum
With targeted 1:1 partnering, dedicated biotech startup and growth showcases, and content tailored to the priorities of biotech leaders, LSX USA offers a focused platform for companies that want to raise their profile, meet the right people and accelerate what comes next.
Take a look at who is speaking at LSX USA 2026...
Focused Content
Early Innovation & Technology Translation
This track focuses on the latest breakthroughs in biotech innovation and the strategies to translate cutting-edge discoveries into impactful solutions. It explores the journey from early-stage research to development, highlighting advancements in biotechnology. Key discussions include fostering academic-industry collaborations, navigating regulatory pathways, and accelerating the commercialization of early-stage biotech innovations.
Capital Markets & Investment Strategies
This track delves into the financial landscape of the biotech sector, offering insights into capital markets, funding trends, and investment strategies. It covers topics such as venture capital, private equity, IPOs, and M&A activity, providing actionable advice for securing funding and scaling biotech businesses. Attendees will gain a deeper understanding of how to align financial strategies with market dynamics and investor expectations.
Pharma Partnering & Deal Making
This track examines the critical role of partnerships and collaborations in driving growth and innovation in the biotech and pharmaceutical industries. It focuses on deal-making strategies, licensing agreements, and co-development opportunities. Attendees will learn how to identify the right partners, negotiate successful deals, and leverage alliances to bring new biotech therapies to market faster and more efficiently.
Market Opportunities & Commercialisation
This track addresses the challenges and opportunities in bringing biotech products to market. It covers market access, pricing strategies, and commercialization pathways for biopharma solutions. Discussions will include navigating global markets, understanding payer dynamics, and optimizing go-to-market strategies to maximize product impact and revenue potential.
Pharma Joining LSX Congress USA
The numbers that matter
1000+
Senior Attendees
300+
Investors
180+
Expert Speakers
2000+
1:1 Partnering Meetings
4
Forums & Workshops
5
Streams
Position your brand in front of 1,000+ biotech, investor and pharma decision-makers
Get access to the people who choose vendors, sign partnerships, and allocate budgets.
Whether you want to build brand authority, generate pipeline, or launch something new to the right room - we build bespoke packages around your specific objectives.
Contact us at partneringsponsorship@informa.com to discuss or download our brochure to view specific opportunities
Our 2026 Sponsors
Maria Shepherd
President
Medi-Vantage LLC
LSX knows its audience, investors, strategic partners and start ups. They do a great job of meeting their needs.
Biotech Week Boston
September 22 - 25 in Boston
Join 5000+ pharma, biotech, investors, academics and solution providers all under one roof with an unrivalled opportunity to connect with the full biopharmaceutical ecosystem.
The exciting event lineup alongside LSX Congress USA:
How can LSX help you?
Intelligence
Acting as an active conduit of industry insights, innovation, trends, best practices & benchmarking
Investment
Leveraging our extensive network we help match life science innovators with the right investors
Community
Organising formal and informal opportunities to foster connections through networking and serendipitous meetings
FAQs
What is LSX Congress USA?
LSX Congress USA (or LSX USA) is a leading event focusing on the US and life sciences sector, bringing together biotech leaders, pharma executives and active investors.
Designed for companies raising capital, pursuing strategic partnerships and preparing for their next phase of growth, the event connects founders, CEOs and senior executives with the people and opportunities that can help move their business forward. Through high-quality content, targeted networking, 1:1 partnering and investor engagement, LSX Congress USA supports biotech companies in building relationships, securing funding and advancing strategic goals.
Whether you are an early-stage biotech or a more established company looking to connect with pharma, LSX Congress USA is a gateway to the partnerships and conversations that drive growth.
Where and when is LSX Congress USA being held?
LSX Congress USA takes place 23-24 September 2026 at the Hynes Convention Center, Boston, USA.
It forms part of Biotech Week Boston, which brings together multiple life science events in the city from 22–25 September 2026.
Who attends LSX USA?
LSX USA brings together a senior and influential audience from across the US life sciences ecosystem. Attendees include biotech founders, CEOs and executive teams, active investors, pharma leaders, and specialist partners supporting company growth. From fundraising and strategic partnerships to investment and business development, the event is designed to connect the people driving the next phase of life science innovation.
- C-suite executives: CEOs, CFOs, COOs, and other senior leaders driving strategy and decision-making.
- Founders and entrepreneurs: Visionaries leading innovative biotech companies.
- Investors and venture capitalists: Active life science investors seeking high-potential companies, investment opportunities and new syndication or partnering conversations.
- Pharma leaders and strategic partners: Pharma executives, business development leaders and partnering teams looking to source innovation, assess opportunities and build relationships with biotech companies.
- Specialist partners and service providers: Organizations offering expertise, resources, and solutions to support business growth.
What companies are speaking at LSX USA?
Our speaking programme features speakers from a diverse mix of biopharmaceutical, pharmaceutical, and corporate venture capital firms. Including:
Boehringer Ingelheim
Ipsen
Johnson & Johnson
Blackstone LIfe Sciences
GSK
Eli Lilly
Angelini Ventures
AbbVie
Servier
Vida Ventures
What is the format and what can I expect at LSX USA?
The event begins with a Pre-Day on September 22, 2026 focusing on CEO and Partnering Forums as closed-door roundtable discussions - View Pre-Day Agenda here.
Then, the main event is held over two days - September 23-24, 2026 - with the following:
- Opportunities to present your company, pitch to investors and pharma
- Qualified 1:1 partnering as a core feature to facilitate deal conversations
- Thought leadership and expert speakers: sessions with interactive Q&A, panel discussions with industry leaders, and real-world case studies and practical frameworks
- Networking breaks and evening receptions
We look forward to seeing you there!
Is LSX USA suitable for start-ups or later stage companies?
Both! From early-stage biotechs navigating fundraising and investor outreach, to more established businesses pursuing strategic partnerships and commercial growth, our event is designed to connect companies with the investors, pharma leaders and expert partners who can help move them forward.
How can I check if I qualify for an Investor Pass?
Please check our terms and conditions on the Investor Qualification page below:
Who organizes LSX Congress USA?
LSX Congress USA is organized by Informa Connect, part of Informa PLC.
Contact us
We do not share any data without consent
Outside vendors who contact you to sell attendee lists are operating independently and without approval of the event organisers.